<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2687-0940</journal-id><journal-title-group><journal-title>Актуальные проблемы медицины</journal-title></journal-title-group><issn pub-type="epub">2687-0940</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.52575/2687-0940-2025-48-3-320-331</article-id><article-id pub-id-type="publisher-id">253</article-id><article-categories><subj-group subj-group-type="heading"><subject>КАРДИОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Acomys Cahirinus как перспективный вид для изучения регенерации миокарда в сравнении с классическими моделями&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Acomys Cahirinus as a Promising Species for Studying Myocardial Regeneration in Comparison with Classical Models&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Хуснутдинова</surname><given-names>Дина Айдаровна</given-names></name><name xml:lang="en"><surname>Khusnutdinova</surname><given-names>Dina A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Набиуллина</surname><given-names>Алина Айратовна</given-names></name><name xml:lang="en"><surname>Nabiullina</surname><given-names>Alina A.</given-names></name></name-alternatives><email>a.ayratovnaa@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Филатов</surname><given-names>Никита Сергеевич</given-names></name><name xml:lang="en"><surname>Filatov</surname><given-names>Nikita S.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Гараев</surname><given-names>Алмаз Талгатович</given-names></name><name xml:lang="en"><surname>Garaev</surname><given-names>Almaz T.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Киясов</surname><given-names>Андрей Павлович</given-names></name><name xml:lang="en"><surname>Kiyasov</surname><given-names>Andrey P.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="epub"><year>2025</year></pub-date><volume>48</volume><issue>3</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/journal-medicine/2025/3/АПМ_2025_Том_48__3_320-331.pdf" /><abstract xml:lang="ru"><p>Инфаркт миокарда остается ведущей причиной смертности во всем мире. Он приводит к необратимой потере кардиомиоцитов и формированию рубцовой ткани. Целью данного обзора является&amp;nbsp;анализ Acomys cahirinus как перспективной модели регенерации миокарда после инфаркта миокарда. Материалы и методы. Был проведен поиск статей за последние 5 лет в базах PubMed, Google Scholar и eLIBRARY по ключевым словам на русском и английском языках, статьи отбирались в соответствии с целью исследования. Результаты:&amp;nbsp;у&amp;nbsp;Acomys&amp;nbsp;выявлено увеличение фракции выброса с 25&amp;nbsp;% до 65&amp;nbsp;% за 4 недели, уменьшение зоны инфаркта, снижение фиброза и активная пролиферация кардиомиоцитов. Особенности Acomys cahirinus влючают повышенную плотность сосудов в рубцовой ткани, &amp;laquo;молодой&amp;raquo; фенотип кардиомиоцитов (преобладание моноядерных диплоидных клеток, наличие T-типа кальциевых каналов) и сниженный воспалительный ответ с доминированием M2-макрофагов. Заключение:&amp;nbsp;Acomys cahirinus&amp;nbsp;представляет собой перспективную модель для изучения механизмов регенерации миокарда, что открывает новые пути для разработки терапии.</p></abstract><trans-abstract xml:lang="en"><p>Myocardial infarction remains the leading cause of mortality worldwide, resulting in irreversible cardiomyocyte loss and scar tissue formation. This review aims to analyze&amp;nbsp;Acomys cahirinus&amp;nbsp;as a promising model for studying myocardial regeneration.&amp;nbsp;Materials and Methods:&amp;nbsp;A systematic search for articles published over the past five years was conducted in PubMed, Google Scholar, and eLIBRARY databases using keywords in Russian and English, selected in accordance with the study objective.&amp;nbsp;Results:&amp;nbsp;In&amp;nbsp;Acomys, a significant restoration of cardiac function was observed: ejection fraction increased from 25% to 65% within four weeks, accompanied by reduced infarct size (18% vs. 76% in&amp;nbsp;Mus), decreased fibrosis, and active cardiomyocyte proliferation. Unique features of&amp;nbsp;Acomys cahirinus&amp;nbsp;include enhanced vascular density in scar tissue, a &amp;quot;youthful&amp;quot; cardiomyocyte phenotype (predominance of mononuclear diploid cells, expression of T-type calcium channels), and a suppressed inflammatory response dominated by M2 macrophages.&amp;nbsp;Conclusion:&amp;nbsp;Acomys cahirinus&amp;nbsp;represents a groundbreaking model for investigating myocardial regeneration mechanisms, offering novel pathways for developing therapies aimed at stimulating cardiac repair in humans. These findings highlight the critical role of immune modulation and extracellular matrix remodeling in regenerative medicine.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>регенерация миокарда</kwd><kwd>Acomys cahirinus</kwd><kwd>инфаркт</kwd><kwd>кардиомиоциты</kwd><kwd>фиброз</kwd><kwd>ангиогенез</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocardial regeneration</kwd><kwd>Acomys cahirinus</kwd><kwd>infarction</kwd><kwd>cardiomyocytes</kwd><kwd>fibrosis</kwd><kwd>angiogenesis</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Никишин А.Г., Пирназаров М.М., Мамарасулов Т.М. 2011. Эффективность терапии ранней постинфарктной стенокардии высокими дозами Симвастатина.&amp;nbsp;Кардиоваскулярная терапия и профилактика, 10(5): 26&amp;ndash;9. doi: 10.15829/1728-8800-2011-5-26-29.</mixed-citation></ref><ref id="B2"><mixed-citation>Оганов Р.Г., Фомина И.Г.&amp;nbsp;2004. Кардиология. Руководство для врачей.&amp;nbsp;М.: Медицина: 397&amp;ndash;480.</mixed-citation></ref><ref id="B3"><mixed-citation>Панкин О.А.&amp;nbsp;2004. Догоспитальные факторы больничной летальности при инфаркте миокарда.&amp;nbsp;Клин. медицина, 4: 40&amp;ndash;5.</mixed-citation></ref><ref id="B4"><mixed-citation>Шукуров Р.Т., Курбанов Р.Д.&amp;nbsp;2011. Антиишемическая и антиангинальная эффективность длительного применения Бисопролола у больных, перенесших инфаркт миокарда. Кардиоваскулярная терапия и профилактика, 2(10): 60&amp;ndash;8. doi: 10.15829/1728-8800-2011-2-60-68</mixed-citation></ref><ref id="B5"><mixed-citation>NICE.&amp;nbsp;2020. Острые коронарные синдромы. Руководство NG185, рекомендации 1.1.27 и 1.2.27.</mixed-citation></ref><ref id="B6"><mixed-citation>Aimo A., Gaggin H., Barison A. et al. 2019. Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction. JACC: Heart Failure, 7(9): 782&amp;ndash;794. doi: 10.1016/j.jchf.2019.06.004</mixed-citation></ref><ref id="B7"><mixed-citation>American Heart Association.&amp;nbsp;2003. Heart Disease and Stroke Statistics. 2004 Update.&amp;nbsp;Dallas, TX: American Heart Association,&amp;nbsp;26.</mixed-citation></ref><ref id="B8"><mixed-citation>Annibali G., Scrocca I., Aranzulla T.C., Meliga E., Maiellaro F., Musumeci G. 2022. &amp;quot;No-Reflow&amp;quot; Phenomenon: A Contemporary Review. Journal of Clinical Medicine, 11(8): 2233. doi: 10.3390/jcm11082233</mixed-citation></ref><ref id="B9"><mixed-citation>Bolli R., Mitrani R.D., Hare J.M., Pepine C.J., Perin E.C., Willerson J.T., Traverse J.H., Henry T.D., Yang&amp;nbsp;P.C., Murphy M.P., March K.L., Schulman I.H., Ikram S., Lee D.P., O&amp;#39;Brien C., Lima J.A., Ostovaneh M.R., Ambale-Venkatesh B., Lewis G., Khan A., Bacallao K., Valasaki K., Longsomboon&amp;nbsp;B., Gee A.P., Richman S., Taylor D.A., Lai D., Sayre S.L., Bettencourt J., Vojvodic&amp;nbsp;R.W., Cohen M.L., Simpson L., Aguilar D., Loghin C., Moy&amp;eacute; L., Ebert R.F., Davis B.R., Simari R.D. for the Cardiovascular Cell Therapy Research Network (CCTRN). 2021. A Phase II Study of Autologous Mesenchymal Stromal Cells and c-kit Positive Cardiac Cells, Alone or in Combination, in Patients with Ischaemic Heart Failure: The CCTRN CONCERT-HF Trial. European Journal of Heart Failure, 23(4): 661&amp;ndash;674. doi: 10.1002/ejhf.2178</mixed-citation></ref><ref id="B10"><mixed-citation>Chen K. et al. 2022. Disrupting Mechanotransduction Decreases Fibrosis and Contracture in Split-Thickness Skin Grafting. Science Translational Medicine, 14(667): eabj9152. doi: 10.1126/scitranslmed.abj9152</mixed-citation></ref><ref id="B11"><mixed-citation>Chen Z., Ishibashi S., Perrey S., Osuga J-i., Gotoda T., Kitamine T., Tamura Y., Okazaki H., Yahagi N., Iizuka&amp;nbsp;Y. 2001. Troglitazone Inhibits Atherosclerosis in Apolipoprotein E Knockout Mice Pleiotropic Effects on CD36 Expression and HDL. Arteriosclerosis, Thrombosis, and Vascular Biology, 21(3): 372&amp;ndash;377. doi: 10.1161/01.atv.21.3.372</mixed-citation></ref><ref id="B12"><mixed-citation>Cutie S., Huang G.N. 2021. Vertebrate Cardiac Regeneration: Evolutionary and Developmental Perspectives. Cell Regeneration, 10: 6. doi: 10.1186/s13619-020-00068-y</mixed-citation></ref><ref id="B13"><mixed-citation>Del Re D.P., Amgalan D., Linkermann A., Liu Q., Kitsis R.N. 2019. Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease. Physiological Reviews, 99(4): 1765&amp;ndash;1817. doi: 10.1152/physrev.00022.2018</mixed-citation></ref><ref id="B14"><mixed-citation>Deng X., Shen A., Jiang L. 2025. Bioinformatics Analysis of JUP in Patients with Acute Myocardial Infarction and its Potential Application in Clinical Prognostic Evaluation. Frontiers in Cardiovascular Medicine, 12: 1531309. doi: 10.3389/fcvm.2025.1531309</mixed-citation></ref><ref id="B15"><mixed-citation>Gardner C.R., Davies K.A., Zhang Y., Brzozowski M., Czabotar P.E., Murphy J.M., Lessene G. 2023. From (Tool) Bench to Bedside: The Potential of Necroptosis Inhibitors. Journal of Medicinal Chemistry, 66(4): 2361&amp;ndash;2385. doi: 10.1021/acs.jmedchem.2c01621</mixed-citation></ref><ref id="B16"><mixed-citation>Gavira J.J., Perez-Ilzarbe M., Abizanda G., Garc&amp;iacute;a-Rodr&amp;iacute;guez A., Orbe J., P&amp;aacute;ramo J.A., Belzunce M., R&amp;aacute;bago&amp;nbsp;G., Barba J., Herreros J. 2006. A Comparison Between Percutaneous and Surgical Transplantation of Autologous Skeletal Myoblasts in a Swine Model of Chronic Myocardial Infarction. Cardiovascular Research, 71(4): 744&amp;ndash;753. doi: 10.1016/j.cardiores.2006.06.011</mixed-citation></ref><ref id="B17"><mixed-citation>Goldman J.A., Poss K.D. 2020. Gene Regulatory Programmes of Tissue Regeneration. Nature Reviews Genetics, 21(9): 511&amp;ndash;525. doi: 10.1038/s41576-020-0239-7</mixed-citation></ref><ref id="B18"><mixed-citation>Haub J. et al. 2019. Intervention of Inflammatory Monocyte Activity Limits Dermal Fibrosis. Journal of Investigative Dermatology, 139(10): 2144&amp;ndash;2153. doi: 10.1016/j.jid.2019.04.006</mixed-citation></ref><ref id="B19"><mixed-citation>Heusch G. 2020. Myocardial Ischaemia&amp;ndash;Reperfusion Injury and Cardioprotection in Perspective. Nature Reviews Cardiology, 17(12): 773&amp;ndash;789. doi: 10.1038/s41569-020-0403-y</mixed-citation></ref><ref id="B20"><mixed-citation>Hu Y., Zhang Y., Han P., Pan Y., Liu J., Li Y., Pan D., Ren J. 2025. Machine Learning-Driven Prediction of Readmission Risk in Heart Failure Patients with Diabetes: Synergistic Assessment of Inflammatory and Metabolic Biomarkers. International Journal of Cardiology, 441: 133743. doi: 10.1016/j.ijcard.2025.133743</mixed-citation></ref><ref id="B21"><mixed-citation>Hui X., Lin Q., Liu K., Gu C., Abdelbaset-Ismail A., Wintergerst K.A., Deng Z., Cai L., Tan Y. 2025. Fibroblast Growth Factor 16: Molecular Mechanisms, Signalling Crosstalk, and Emerging Roles in Cardiac Biology and Metabolic Regulation. Pharmacological Research, 218: 107858. doi: 10.1016/j.phrs.2025.107858</mixed-citation></ref><ref id="B22"><mixed-citation>Li B., Wang R., Wang Y., Stief C.G., Hennenberg M. 2020. Regulation of Smooth Muscle Contraction by Monomeric non-RhoA GTPases. British Journal of Pharmacology, 177(17): 3865&amp;ndash;3877. doi: 10.1111/bph.15172</mixed-citation></ref><ref id="B23"><mixed-citation>Lubberding A.F., Sattler S.M., Fleth&amp;oslash;j M., Tfelt-Hansen J., Jespersen T. 2020. Comparison of Hemodynamics, Cardiac Electrophysiology, and Ventricular Arrhythmia in an Open- and a Closed-Chest Porcine Model of Acute Myocardial Infarction. American Journal of Physiology-Heart and Circulatory Physiology, 318(2): H391&amp;ndash;H400. doi: 10.1152/ajpheart.00406.2019</mixed-citation></ref><ref id="B24"><mixed-citation>Maden M., Varholick J.A. 2020. Model Systems for Regeneration: The Spiny Mouse, Acomys Cahirinus. Development, 147(4): dev167718. doi: 10.1242/dev.167718</mixed-citation></ref><ref id="B25"><mixed-citation>Martin T.P., MacDonald E.A., Elbassioni A.A.M., O&amp;#39;Toole D., Zaeri A.A.I., Nicklin S.A., Gray G.A., Loughrey C.M. 2022. Preclinical Models of Myocardial Infarction: From Mechanism to Translation. British Journal of Pharmacology, 179(5): 770&amp;ndash;791. doi: 10.1111/bph.15595</mixed-citation></ref><ref id="B26"><mixed-citation>Mart&amp;iacute;nez-Falguera D., Fadeuilhe E., Teis A., Aranyo J., Adeli&amp;ntilde;o R., Bisbal F., Rodriguez-Leor O., G&amp;aacute;lvez-Mont&amp;oacute;n C. 2021. Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model. Journal of Visualized Experiments, (177): e63172. doi: 10.3791/63172</mixed-citation></ref><ref id="B27"><mixed-citation>Meng Y., Garnish S.E., Davies K.A., Black K.A., Leis A.P., Horne C.R., Hildebrand J.M., Hoblos H., Fitzgibbon C., Young S.N., Dite T., Dagley L.F., Venkat A., Kannan N., Koide A., Koide S., Glukhova&amp;nbsp;A., Czabotar P.E., Murphy J.M. 2023. Phosphorylation-Dependent Pseudokinase Domain Dimerization Drives Full-Length MLKL Oligomerization. Nature Communications, 14: 6804. doi: 10.1038/s41467-023-42255-w</mixed-citation></ref><ref id="B28"><mixed-citation>Padro T., Manfrini O., Bugiardini R., Canty J., Cenko E., De Luca G., Duncker D.J., Eringa E.C., Koller A., Tousoulis D., Trifunovic D., Vavlukis M., de Wit C., Badimon L., ESC Working Group on Coronary Pathophysiology and Microcirculation. 2020. ESC Working Group on Coronary Pathophysiology and Microcirculation Position Paper on &amp;lsquo;Coronary Microvascular Dysfunction in Cardiovascular Disease&amp;rsquo;. Cardiovascular Research, 116(4): 741&amp;ndash;755. doi: 10.1093/cvr/cvaa003</mixed-citation></ref><ref id="B29"><mixed-citation>Peng H., Shindo K., Donahue R.R., Gao E., Ahern B.M., Levitan B.M., Tripathi H., Powell D., Noor A., Elmore G.A., Satin J., Seifert A.W., Abdel-Latif A. 2021. Adult Spiny Mice (Acomys) Exhibit Endogenous Cardiac Recovery in Response to Myocardial Infarction. NPJ Regenerative Medicine, 6(1): 74. doi: 10.1038/s41536-021-00186-4</mixed-citation></ref><ref id="B30"><mixed-citation>Perin E., Borow K., Henry T. et al. 2023. Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients with Heart Failure. Journal of the American College of Cardiology, 81(9): 849&amp;ndash;863. doi: 10.1016/j.jacc.2022.11.061</mixed-citation></ref><ref id="B31"><mixed-citation>Sicklinger F., Zhang Y., Lavine K.J., Simon N., Bucher V., Jugold M., Lehmann L., Konstandin M.H., Katus&amp;nbsp;H.A., Leuschner F. 2020. A Minimal-Invasive Approach for Standardized Induction of Myocardial Infarction in Mice. Circulation Research, 127(9): 1214&amp;ndash;1216. doi: 10.1161/CIRCRESAHA.120.317794</mixed-citation></ref><ref id="B32"><mixed-citation>St&amp;uuml;rzebecher P.E., Kralisch S., Schubert M.R., Filipova V., Hoffmann A., Oliveira F., Sheikh B.N., Bl&amp;uuml;her&amp;nbsp;M., Kogel A., Scholz M., Kokot K.E., Erbe S., Kneuer J.M., Ebert T., Fasshauer M., Miehle K., Laufs U., T&amp;ouml;njes A., Boeckel J.N. 2022. Leptin Treatment Has Vasculo-Protective Effects in Lipodystrophic Mice. Proceedings of the National Academy of Sciences of the United States of America, 119(40): e2110374119. doi: 10.1073/pnas.2110374119</mixed-citation></ref><ref id="B33"><mixed-citation>Yang Y., Yu Z., Geng J., Liu M., Liu N., Li P., Hong W., Yue S., Jiang H., Ge H., Qian F., Xiong W., Wang&amp;nbsp;P., Song S., Li X., Fan Y., Liu X. 2022. Cytosolic Peptides Encoding CaV1 C-termini Downregulate the Calcium Channel Activity-Neuritogenesis Coupling. Communications Biology, 5: 484. doi: 10.1038/s42003-022-03438-1</mixed-citation></ref><ref id="B34"><mixed-citation>Yin J.L., Wu Y., Yuan Z.W., Gao X.H., Chen H.D. 2020. Advances in Scarless Foetal Wound Healing and Prospects for Scar Reduction in Adults. Cell Proliferation, 53(11): e12916. doi: 10.1111/cpr.12916</mixed-citation></ref></ref-list></back></article>